Merrimack Pharmaceuticals
MACK
#7939
Rank
A$0.35 B
Marketcap
$23.72
Share price
0.00%
Change (1 day)
3.71%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2023 (TTM): -$0.17

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.17. In 2022 the company made an earnings per share (EPS) of -$0.17 an increase over its 2021 EPS that were of -$0.28.

EPS history for Merrimack Pharmaceuticals from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.17-4.18%
2022-$0.17-38.89%
2021-$0.28-25%
2020-$0.38-81.54%
2019-$2.04-56.95%
2018-$4.73-108.5%
2017$55.67-390.35%
2016-$19.17-7.35%
2015-$20.6965%
2014-$12.54-39.39%
2013-$20.69-54.01%
2012-$45.00-53.71%
2011-$97.2140.37%
2010-$69.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$4.99-2,991.14%๐Ÿ‡ซ๐Ÿ‡ท France
-$1.32 663.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.53 209.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.96 1,618.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.84 5,027.27%๐Ÿ‡บ๐Ÿ‡ธ USA